RT @P_McGettigan: @drjohnm Have a look at this classic from Desmond Julian no less https://t.co/VoKz5aeiAj
RT @P_McGettigan: @DavidJuurlink @drjohnm Have a look at this classic from Desmond Julian no less https://t.co/VoKz5aeiAj
RT @HeartSisters: You had me at "...Little is known about benefits/risks of longterm use of cardiovascular drugs. Clinical trials rarely go…
RT @HeartSisters: You had me at "...Little is known about benefits/risks of longterm use of cardiovascular drugs. Clinical trials rarely go…
You had me at "...Little is known about benefits/risks of longterm use of cardiovascular drugs. Clinical trials rarely go beyond a few years of follow-up, but patients are often given continuous treatment with multiple drugs well into old age." https://t.c
@DavidJuurlink @drjohnm Have a look at this classic from Desmond Julian no less https://t.co/VoKz5aeiAj
@drjohnm Have a look at this classic from Desmond Julian no less https://t.co/VoKz5aeiAj
RT @NeLLLieBly: Long-Term Use of Cardiovascular Drugs https://t.co/NTlH8epiT5 Excellent thoughtful piece that every doctor & person over ag…
RT @NeLLLieBly: Long-Term Use of Cardiovascular Drugs https://t.co/NTlH8epiT5 Excellent thoughtful piece that every doctor & person over ag…
RT @NeLLLieBly: Long-Term Use of Cardiovascular Drugs https://t.co/NTlH8epiT5 Excellent thoughtful piece that every doctor & person over ag…
Long-Term Use of Cardiovascular Drugs https://t.co/NTlH8epiT5 Excellent thoughtful piece that every doctor & person over age 30 should read.
Great paper and great to see 1st author a medical student! https://t.co/YthWL7Zq3Q
RT @drjohnm: Pivotal paper for clinicians. See also this review on (lack of) evidence of long-term benefit of CV drugs https://t.co/ZT682W2…
RT @drjohnm: Pivotal paper for clinicians. See also this review on (lack of) evidence of long-term benefit of CV drugs https://t.co/ZT682W2…
RT @drjohnm: Pivotal paper for clinicians. See also this review on (lack of) evidence of long-term benefit of CV drugs https://t.co/ZT682W2…
RT @drjohnm: Pivotal paper for clinicians. See also this review on (lack of) evidence of long-term benefit of CV drugs https://t.co/ZT682W2…
RT @drjohnm: Pivotal paper for clinicians. See also this review on (lack of) evidence of long-term benefit of CV drugs https://t.co/ZT682W2…
Worth reading many times over! https://t.co/J4bzBuMzZt
RT @drjohnm: Pivotal paper for clinicians. See also this review on (lack of) evidence of long-term benefit of CV drugs https://t.co/ZT682W2…
Pivotal paper for clinicians. See also this review on (lack of) evidence of long-term benefit of CV drugs https://t.co/ZT682W2Rmg https://t.co/EUtTl7atRv
RT @drjohnm: We should all re-read this important @JACCJournals SOA paper when thinking about FOURIER https://t.co/ZT682W2Rmg cc @Dr_BowTie…
RT @drjohnm: We should all re-read this important @JACCJournals SOA paper when thinking about FOURIER https://t.co/ZT682W2Rmg cc @Dr_BowTie…
RT @drjohnm: We should all re-read this important @JACCJournals SOA paper when thinking about FOURIER https://t.co/ZT682W2Rmg cc @Dr_BowTie…
RT @drjohnm: We should all re-read this important @JACCJournals SOA paper when thinking about FOURIER https://t.co/ZT682W2Rmg cc @Dr_BowTie…
RT @drjohnm: We should all re-read this important @JACCJournals SOA paper when thinking about FOURIER https://t.co/ZT682W2Rmg cc @Dr_BowTie…
RT @drjohnm: We should all re-read this important @JACCJournals SOA paper when thinking about FOURIER https://t.co/ZT682W2Rmg cc @Dr_BowTie…
RT @drjohnm: We should all re-read this important @JACCJournals SOA paper when thinking about FOURIER https://t.co/ZT682W2Rmg cc @Dr_BowTie…
RT @drjohnm: We should all re-read this important @JACCJournals SOA paper when thinking about FOURIER https://t.co/ZT682W2Rmg cc @Dr_BowTie…
RT @drjohnm: We should all re-read this important @JACCJournals SOA paper when thinking about FOURIER https://t.co/ZT682W2Rmg cc @Dr_BowTie…
We should all re-read this important @JACCJournals SOA paper when thinking about FOURIER https://t.co/ZT682W2Rmg cc @Dr_BowTie65 #ACC17 https://t.co/UsrtrJxHnb
読みたいが有料か... Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care. - PubMed - NCBI https://t.co/AHtx1EztjX
@JohnTuckerPhD @adamjshay @medskep Long-term effects of many CV drugs unknown. https://t.co/1DYfAV1Prb < Fuster's commentary remarkable
RT @timothywflynn: Serious Concerns of Long-Term Use of Cardiovascular Drugs in our aging population. Adults on 6 drugs is common! http://t…
RT @timothywflynn: Serious Concerns of Long-Term Use of Cardiovascular Drugs in our aging population. Adults on 6 drugs is common! http://t…
RT @Deprescribing: Long-term use of cardiovascular drugs: challenges for research & for patient care Includes section on #deprescribing ht…
RT @Deprescribing: Long-term use of cardiovascular drugs: challenges for research & for patient care Includes section on #deprescribing ht…
Long-term use of cardiovascular drugs: challenges for research & for patient care Includes section on #deprescribing http://t.co/TYnMeQ0E5a
Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care: http://t.co/KfoFsZD84V #ptsafety #prescribing
RT @timothywflynn: Serious Concerns of Long-Term Use of Cardiovascular Drugs in our aging population. Adults on 6 drugs is common! http://t…
RT @timothywflynn: Serious Concerns of Long-Term Use of Cardiovascular Drugs in our aging population. Adults on 6 drugs is common! http://t…
Serious Concerns of Long-Term Use of Cardiovascular Drugs in our aging population. Adults on 6 drugs is common! http://t.co/5694d48P1l
Link: Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care. - PubMed - NCBI http://t.co/q8gKwPuWrn
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
RT @DrRitaMc: Sounds like @Deprescribing to me...Long-Term Use of Cardiovascular Drugs:Challenges for Research & for Patient Care. http://t…
Sounds like @Deprescribing to me...Long-Term Use of Cardiovascular Drugs:Challenges for Research & for Patient Care. http://t.co/exrFncb3Nk
RT @ImMSanFer: Interesante crítica a la falta de datos con AAS y estatinas a muy largo plazo, especialmente en población anciana. http://t…
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
RT @JACCJournals: Do we really know? New work in #JACC takes us through the issues of long-term CV drug use – challenges and gaps http://t.…
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
RT @JACCJournals: Do we really know? New work in #JACC takes us through the issues of long-term CV drug use – challenges and gaps http://t.…
Do we really know? New work in #JACC takes us through the issues of long-term CV drug use – challenges and gaps http://t.co/uYkU79QFSb
Little known about benefits & risks of long-term use of #cardiovascular #drugs. http://t.co/0PoWUIQZ8D #healthcare #patients
RT @RB_Cavalcanti: Another "game changer"? http://t.co/iA7WKE8ERS @FralickMike @bourneauguste @SteveGauthier_ @dunbar37 @mjbeyak @AngelaMCh…
Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care. http://t.co/UAnD4xoo2h
RT @pash22: Long-Term Use of Cardiovascular Drugs:Challenges for Research and for Patient Care https://t.co/ADa71f9geo
Long-Term Use of Cardiovascular Drugs:Challenges for Research and for Patient Care https://t.co/ADa71f9geo
Another "game changer"? http://t.co/iA7WKE8ERS @FralickMike @bourneauguste @SteveGauthier_ @dunbar37 @mjbeyak @AngelaMCheung HT@drjohnm
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care http://t.co/nawrGgrvJB
Long-Term Use of Cardiovascular Drugs http://t.co/iyO3FBZt4M @drjohnm @RichardLehman1 say most imp. paper of the year but .it's locked up
Long-Term Use of #Cardiovascular Drugs: Challenges for #Research and for Patient Care http://t.co/0BDHgsaBFe #compliance #polypharmacy
RT @medskep: Long-Term Use of Cardiovascular Drugs http://t.co/iyO3FBZt4M @drjohnm @RichardLehman1 say most imp. paper of the year but .it…
RT @medskep: Long-Term Use of Cardiovascular Drugs http://t.co/iyO3FBZt4M @drjohnm @RichardLehman1 say most imp. paper of the year but .it…
RT @medskep: Long-Term Use of Cardiovascular Drugs http://t.co/iyO3FBZt4M @drjohnm @RichardLehman1 say most imp. paper of the year but .it…
Long-Term Use of Cardiovascular Drugs http://t.co/iyO3FBZt4M @drjohnm @RichardLehman1 say most imp. paper of the year but .it's locked up
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
Must read: Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care http://t.co/a3wqhnn55k via @jaccjournals
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
RT @drjohnm: This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster a…
This is—by far--the most important cardiology paper published this yr> http://t.co/YiN7Xj13pQ < Kudos to Dr. Valentin Fuster and @ACCinTouch
RT @ImMSanFer: Interesante crítica a la falta de datos con AAS y estatinas a muy largo plazo, especialmente en población anciana. http://t…
RT @ImMSanFer: Interesante crítica a la falta de datos con AAS y estatinas a muy largo plazo, especialmente en población anciana. http://t…
RT @ImMSanFer: Interesante crítica a la falta de datos con AAS y estatinas a muy largo plazo, especialmente en población anciana. http://t…
RT @ImMSanFer: Interesante crítica a la falta de datos con AAS y estatinas a muy largo plazo, especialmente en población anciana. http://t…
RT @ImMSanFer: Interesante crítica a la falta de datos con AAS y estatinas a muy largo plazo, especialmente en población anciana. http://t…
RT @ImMSanFer: Interesante crítica a la falta de datos con AAS y estatinas a muy largo plazo, especialmente en población anciana. http://t…
Interesante crítica a la falta de datos con AAS y estatinas a muy largo plazo, especialmente en población anciana. http://t.co/t7DMH0OCac
RT @drjohnm: Timely important review in JACC on the utter lack of data for "long-term" use of ASA, ACE,BB, #statins. #deprescribe http://t…
RT @drjohnm: Timely important review in JACC on the utter lack of data for "long-term" use of ASA, ACE,BB, #statins. #deprescribe http://t…
Timely important review in JACC on the utter lack of data for "long-term" use of ASA, ACE,BB, #statins. #deprescribe http://t.co/Lw0bFmHcgz
Long-Term Use of #Cardiovascular #Drugs: Challenges for Research and for Patient Care │ http://t.co/CTVYJILbsk